ABSTRACT
Opioids exert analgesic effects by agonizing opioid receptors and activating signaling pathways coupled to receptors such as G-protein and/or ß-arrestin. Concomitant respiratory depression (RD) is a common clinical problem, and improvement of RD is usually achieved with specific antagonists such as naloxone; however, naloxone antagonizes opioid analgesia and may produce more unknown adverse effects. In recent years, researchers have used various methods to isolate opioid receptor-mediated analgesia and RD, with the aim of preserving opioid analgesia while attenuating RD. At present, the focus is mainly on the development of new opioids with weak respiratory inhibition or the use of non-opioid drugs to stimulate breathing. This review reports recent advances in novel opioid agents, such as mixed opioid receptor agonists, peripheral selective opioid receptor agonists, opioid receptor splice variant agonists, biased opioid receptor agonists, and allosteric modulators of opioid receptors, as well as in non-opioid agents, such as AMPA receptor modulators, 5-hydroxytryptamine receptor agonists, phosphodiesterase-4 inhibitors, and nicotinic acetylcholine receptor agonists.
Subject(s)
Analgesics, Opioid , Respiratory Insufficiency , Humans , Respiratory Insufficiency/chemically induced , Respiratory Insufficiency/drug therapy , Analgesics, Opioid/adverse effects , Analgesics, Opioid/therapeutic use , Receptors, Opioid/drug effects , Receptors, Opioid/metabolism , Receptors, Opioid/agonists , Narcotic Antagonists/therapeutic use , Narcotic Antagonists/pharmacologyABSTRACT
Acetaminophen (paracetamol) is one of the most popular analgesics for the management of fever and pain but few reports have investigated its antidepressant-like effect. Moreover, the role of the opioidergic pathway has been indicated in depression pathophysiology. This study aimed to examine the involvement of the opioid receptors in the antidepressant-like effect of acetaminophen after acute and sub-chronic administration using mice forced swimming test (FST). Our finding showed that administration of acetaminophen (50 and 100â¯mg/kg, i.p.) 30â¯min before the FST produced an antidepressant effect which was reduced by naloxone (1â¯mg/kg, i.p., a nonselective opioid receptor antagonist). Moreover, we observed that acetaminophen in higher doses (200 and 400â¯mg/kg) was ineffective. Also, the response of the non-effective dose of acetaminophen (25â¯mg/kg) was potentiated by the non-effective dose of morphine (0.1â¯mg/kg) in the FST that was antagonized by naloxone. Also, in contrast to morphine (10â¯mg/kg), acetaminophen (100â¯mg/kg, i.p.) induced neither tolerance to the anti-immobility behavior nor withdrawal syndrome after repeated administration. In addition, RT-PCR showed that hippocampal mu- and kappa-opioid receptor mRNA expression increased in mice after repeated administration of acetaminophen; however, morphine therapy for 6 days did not affect kappa-opioid receptor expression. Our findings demonstrated that acetaminophen in lower doses but not high doses revealed an antidepressant-like activity without inducing tolerance and withdrawal syndromes. Moreover, the observed effect of acetaminophen may be via altering the opioid system, particularly hippocampal mu- and kappa-receptors.
Subject(s)
Acetaminophen , Antidepressive Agents , Dose-Response Relationship, Drug , Naloxone , Narcotic Antagonists , Animals , Acetaminophen/pharmacology , Acetaminophen/administration & dosage , Male , Mice , Antidepressive Agents/pharmacology , Antidepressive Agents/administration & dosage , Naloxone/pharmacology , Narcotic Antagonists/pharmacology , Narcotic Antagonists/administration & dosage , Swimming , Depression/drug therapy , Depression/metabolism , Morphine/pharmacology , Morphine/administration & dosage , Hippocampus/drug effects , Hippocampus/metabolism , Disease Models, Animal , Analgesics, Opioid/pharmacology , Analgesics, Opioid/administration & dosage , Analgesics, Non-Narcotic/pharmacology , Analgesics, Non-Narcotic/administration & dosage , Receptors, Opioid/metabolism , Receptors, Opioid/drug effects , Receptors, Opioid, mu/metabolism , Receptors, Opioid, mu/drug effectsABSTRACT
Aunque no existe un analgésico ni una vía de administración neuroaxial ideal, los clínicos continúan buscando compuestos con cualidades que puedan acercarse a esta idea. Sin embargo, se ha demostrado que la administración espinal de un medicamento opioide no siempre garantiza una analgesia segmentaria y selectiva en la médula espinal. Este punto es cierto debido a la recaptación parcial del fármaco a la circulación sistémica sanguínea que alcanza receptores opioides cerebrales específicos, además de las diferencias que se explican por las variaciones en la tasa de eliminación del líquido cefalorraquídeo. La evidencia publicada de estudios experimentales en humanos o animales indica que la biodisponibilidad en la biofase medular está correlacionada negativamente con la liposolubilidad. Por lo tanto, la analgesia espinal es mayor para los opioides hidrófilos como la morfina, que para los lipófilos como el fentanilo, el sufentanilo o el alfentanilo
Although there is no either ideal analgesic or route of neuraxial administration, clinicians alike continue to search for compounds with qualities which may approach this idea. However, it's a demonstrated fact that spinal administration of an opioid drug does not always guarantee segmental and selective analgesia into the spinal cord. This point is valid due to partial reuptake of the drug to systemic blood circulation reaching specific brain opioid receptors, rather than the differences are explained by variations in the clearance rate from the cerebrospinal fluid. Published evidence from either human or animal experimental studies indicates that bioavailability in the spinal cord biophase is negatively correlated with liposolubility. Therefore, opioid spinal cord bioavailability is higher for hydrophilic opioids like morphine, than for lipophilic ones such as fentanyl, sufentanil or alfentanil
Subject(s)
Humans , Acute Pain/drug therapy , Spinal Cord/drug effects , Analgesics, Opioid/pharmacokinetics , Biological Availability , Cerebrospinal Fluid/drug effects , Pain Management/methods , Receptors, Opioid/drug effectsABSTRACT
ABSTRACT Purposes: To evaluate the effects of nalbuphine 1% on the expression of metalloproteinase 1 (MMP-1), metalloproteinase 9 (MMP-9), and opioid growth factor (OGF) in rabbit corneas after lamellar keratectomy. Methods: The rabbits were assigned to two groups: group nalbuphine (GN, n=30), which received 30 µL of nalbuphine 1% in 4 daily applications at regular intervals until corneal epithelialization, and group control (GC, n=30), which received physiological saline solution under the same conditions adopted in GN. The corneas were collected for immunohistochemistry on days 1, 3, 5, 7, and 9 after lamellar keratectomy, and the expressions of MMP-1, MMP-9, and OGF were analyzed. Results: The expressions of MMP-1 and MMP-9 increased until day 5 of the evaluation, with no differences observed between GN and GC (p>0.05). On days 7 and 9, significant reductions were observed in the expression of MMP-1 (p<0.01), with no differences observed between GN and GC (p>0.05). The expression of OGF was constant in all periods (p>0.05), restricted to the corneal epithelium, and there was no difference between the groups (p>0.05). Conclusions: The study results showed that nalbuphine 1% did not alter the expression patterns of MMP-1, MMP-9, and OGF in rabbit corneas after lamellar keratectomy. .
RESUMO Objetivos: Avaliar os efeitos da nalbufina 1% sobre a expressão da metaloproteinase 1 (MMP-1), da metaloproteinase 9 (MMP-9) e do fator de crescimento opióide (OGF), em córneas de coelhos submetidas à ceratectomia lamelar. Métodos: Constituíram-se dois grupos: grupo nalbufina (GN, n=30), que recebeu 30 µL de nalbufina 1% em 4 aplicações diárias, a intervalos regulares, até a epitelização corneal; controle (GC, n=30), que recebeu solução salina nas mesmas condições adotadas no GN. As córneas foram colhidas para imuno-histoquímica decorridos 1, 3, 5, 7 e 9 dias das ceratectomias lamelares, visando a se avaliarem as MMP-1, MMP-9 e OGF. Resultados: A expressão das MMP-1 e de MMP-9 se elevou até o quinto dia de avaliação, sem diferença entre GN e GC (p>0,05). Nos dias 7 e 9, observou-se redução significativa na expressão das enzimas (p<0,01), sendo que diferenças não foram observadas entre os grupos (p>0,05). O OGF exibiu imunomarcação constante em todos os períodos (p>0,05), restrita ao epitélio corneal. Não foram encontradas diferenças entre os grupos (p>0,05). Conclusões: Com base dos resultados obtidos, há como admitir que a nalbufina 1% não alterou o padrão de expressão da MMP-1, da MMP-9 e do OGF em córneas de coelhos submetidas à ceratectomia lamelar. .
Subject(s)
Animals , Male , Rabbits , Analgesics, Opioid/pharmacology , Epithelium, Corneal/drug effects , Matrix Metalloproteinase 1/drug effects , Matrix Metalloproteinase 9/drug effects , Nalbuphine/pharmacology , Receptors, Opioid/drug effects , Analgesics, Opioid/administration & dosage , Corneal Stroma/metabolism , Corneal Stroma/pathology , Epithelium, Corneal/metabolism , Immunohistochemistry , Models, Animal , Matrix Metalloproteinase 1/metabolism , Matrix Metalloproteinase 9/metabolism , Nalbuphine/administration & dosage , Receptors, Opioid/metabolism , Refractive Surgical Procedures/methodsABSTRACT
BACKGROUND AND OBJECTIVES: Tramadol is known as a central acting analgesic drug, used for the treatment of moderate to severe pain. Local analgesic effect has been demonstrated, in part due to local anesthetic-like effect, but other mechanisms remain unclear. The role of peripheral opioid receptors in the local analgesic effect is not known. In this study, we examined role of peripheral opioid receptors in the local analgesic effect of tramadol in the plantar incision model. METHODS: Young male Wistar rats were divided into seven groups: control, intraplantar tramadol, intravenous tramadol, intravenous naloxone-intraplantar tramadol, intraplantar naloxone-intraplantar tramadol, intravenous naloxone-intravenous tramadol, and intravenous naloxone. After receiving the assigned drugs (tramadol 5 mg, naloxone 200 µg or 0.9% NaCl), rats were submitted to plantar incision, and withdrawal thresholds after mechanical stimuli with von Frey filaments were assessed at baseline, 10, 15, 30, 45 and 60 min after incision. RESULTS: Plantar incision led to marked mechanical hyperalgesia during the whole period of observation in the control group, no mechanical hyperalgesia were observed in intraplantar tramadol group, intraplantar naloxone-intraplantar tramadol group and intravenous naloxone-intraplantar tramadol. In the intravenous tramadol group a late increase in withdrawal thresholds (after 45 min) was observed, the intravenous naloxone-intravenous tramadol group and intravenous naloxone remained hyperalgesic during the whole period. CONCLUSIONS: Tramadol presented an early local analgesic effect decreasing mechanical hyperalgesia induced by plantar incision. This analgesic effect was not mediated by peripheral opioid receptors. .
JUSTIFICATIVA E OBJETIVOS: Tramadol é conhecido como um fármaco analgésico de ação central, usado para o tratamento de dor moderada a grave. O efeito analgésico local foi demonstrado, em parte devido ao efeito semelhante ao anestésico local, mas outros mecanismos permanecem obscuros. O papel dos receptores opioides periféricos no efeito analgésico local não é conhecido. Neste estudo, examinamos o papel dos receptores opioides periféricos no efeito analgésico local de tramadol em modelo de incisão plantar. MÉTODOS: Ratos Wistar, jovens e machos, foram divididos em sete grupos: controle, tramadol intraplantar, tramadol intravenoso, tramadol intraplantar-naloxona intravenosa, tramadol intraplantar-naloxona intraplantar, tramadol intravenoso-naloxona intravenosa e naloxona intravenosa. Após receber os medicamentos designados (5 mg de tramadol, 200 mg de naloxona ou NaCl a 0,9%, os ratos foram submetidos à incisão plantar e os limiares de retirada após estímulos mecânicos com filamentos de von Frey foram avaliados no início do estudo e nos minutos 10, 15, 30, 45 e 60 após a incisão. RESULTADOS: A incisão plantar levou à hiperalgesia mecânica acentuada durante todo o período de observação no grupo controle; hiperalgesia mecânica não foi observada nos grupos tramadol intraplantar, tramadol intraplantar-naloxona intraplantar e tramadol intraplantar-naloxona intravenosa. No grupo tramadol intravenoso, um aumento tardio do limiar de retirada (após 45 minutos) foi observado. Os grupos tramadol intravenoso-naloxona intravenosa e naloxona intravenosa permaneceram hiperalgésicos durante todo o período. CONCLUSÕES: Tramadol apresentou efeito analgésico local inicial e diminuiu a hiperalgesia mecânica induzida pela incisão plantar. Esse efeito analgésico não foi mediado por receptores opioides periféricos. .
JUSTIFICACIÓN Y OBJETIVOS: Al tramadol se le conoce como un medicamento analgésico de acción central usado para el tratamiento del dolor moderado a intenso. El efecto analgésico local quedó demostrado, en parte, a causa del efecto similar al del anestésico local, pero otros mecanismos permanecen sin clarificar. El rol de los receptores opiáceos periféricos en el efecto analgésico local no se conoce. En este estudio, examinamos el papel de los receptores opiáceos periféricos en el efecto analgésico local del tramadol en un modelo de incisión plantar. MÉTODOS: Ratones Wistar, jóvenes y machos, fueron divididos en 7 grupos: control, tramadol intraplantar, tramadol intravenoso, tramadol intraplantar-naloxona intravenosa, tramadol intraplantar-naloxona intraplantar, tramadol intravenoso-naloxona intravenosa, y naloxona intravenosa. Después de recibir los medicamentos designados (5 mg de tramadol, 200 µg de naloxona o NaCl al 0,9%), los ratones fueron sometidos a la incisión plantar, y los umbrales de retirada de la pata posteriores a los estímulos mecánicos con filamentos de von Frey fueron evaluados al inicio del estudio y en los minutos 10, 15, 30, 45 y 60 después de la incisión. RESULTADOS: La incisión plantar conllevó hiperalgesia mecánica acentuada durante todo el período de observación en el grupo control; la hiperalgesia mecánica no fue observada en los grupos tramadol intraplantar, tramadol intraplantar-naloxona intraplantar, y tramadol intraplantar-naloxona intravenosa. En el grupo tramadol intravenoso, fue observado un aumento tardío del umbral de retirada (después de 45 min); los grupos tramadol intravenoso-naloxona intravenosa y naloxona intravenosa permanecieron hiperalgésicos durante todo el período. CONCLUSIONES: El tramadol presentó un efecto analgésico local inicial, disminuyendo la hiperalgesia mecánica inducida por la incisión plantar. Ese efecto analgésico no fue mediado por receptores opiáceos periféricos. .
Subject(s)
Animals , Male , Rats , Pain, Postoperative/drug therapy , Tramadol/pharmacology , Hyperalgesia/drug therapy , Analgesics, Opioid/pharmacology , Time Factors , Tramadol/administration & dosage , Rats, Wistar , Receptors, Opioid/drug effects , Receptors, Opioid/metabolism , Disease Models, Animal , Analgesics, Opioid/administration & dosage , Injections , Injections, Intravenous , Naloxone/administration & dosage , Naloxone/pharmacologyABSTRACT
The participation of opioids in the antinociceptive effect of electroacupuncture was evaluated in terms of nociception produced by thermal stimuli applied to the face of male Wistar rats, weighing 180-230 g. Electrical stimulation (bipolar and asymmetric square wave with 0.5 mA intensity for 20 min) of acupoint St36, located in the anterior tibial muscle 10 mm distal to the knee joint, induced antinociception in the present model, which was maintained for 150 min. Acupoint LI4, located in the junction of the first and second metacarpal bones, did not achieve antinociception at any frequency studied (5 Hz: 1.7 ± 0.1; 30 Hz: 1.8 ± 0.1; 100 Hz: 1.7 ± 0.1 vs 1.4 ± 0.2). The antinociception obtained by stimulation of acupoint St36 was only achieved when high frequency 100 Hz (3.0 ± 0.2 vs 1.0 ± 0.1) was used, and not with 5 or 30 Hz (1.2 ± 0.2 and 0.7 ± 0.1 vs 1.0 ± 0.1). The antinociceptive effect of acupuncture occurred by opioid pathway activation, since naloxone (1 and 2 mg/kg, subcutaneously) antagonized it (1.8 ± 0.2 and 1.7 ± 0.2 vs 3.0 ± 0.1).
Subject(s)
Animals , Male , Rats , Acupuncture Points , Acupuncture Analgesia/methods , Electroacupuncture , Facial Pain/therapy , Receptors, Opioid/physiology , Naloxone/pharmacology , Narcotic Antagonists/pharmacology , Pain Measurement , Pain Threshold , Rats, Wistar , Receptors, Opioid/drug effectsABSTRACT
The influence of chronica pre- and postnatal naltrexone exposure on the sensitivity of off spring to the locomotor effects of morphine was investigated i C-57 Black mice. Pregnant mice were injected subcutaneously (sc) with either saline (0.1 ml/10 g) or naltrexone (10 mg/kg) twice daily during gestation and throughout lactation, 21 days postpartum. One, three and seven weeks after bith, male offspring were tested for locomotor activity. At 7 weeks of age, dose-response curves were obtained with morphine (10, 31.6, and 100 mg/kg) and amphetamine (0.31, 10 and 31.6 mg/kg) in naltrexone-pretreated and in saline-treated animals. Naltrexone exposure during gestation and lactation resulted in an augmented sensitivity of offspring to the locomotor activity increasing effects of morphine. In these animals, the dose-response relationship for the effect of morphine on locomotor activity was displaced to the left about threefold. In contrast, naltrexone exposure did not alter the sensitivity of offspring to amphetamine. It was also found that ofsspring of naltrexone-treated animals have significantly greater spontaneous locomotor activity than that of the offspring of saline treated mothers. The increased locomotor activity persisted for at least 4 weeks after the last injection of naltrexone. These findings indicate that chronic opioid receptor blockade during gestation and early portnatal development induces supersensitivity to the locomotor effects of morphine and is associated with long-lasting behavioral alterations
Subject(s)
Animals , Male , Female , Pregnancy , Mice , Animals, Newborn , Narcotic Antagonists/pharmacology , Hyperkinesis/chemically induced , Maternal-Fetal Exchange , Morphine/pharmacology , Motor Activity/drug effects , Naltrexone/pharmacology , Receptors, Opioid/drug effectsABSTRACT
The invovlement of opiodi receptors in the analgesic response was evaluated by the tail-immersion test in simultaneously adrenalectomized and ovariectomized female Wistar rats (210-250g). The reaction time (mean ñ SEM) for tail withdrawal from hot water decreased significantly 2 weeks after surgery (3.52 ñ 0.20 s) when compared to intact animals (6.09 ñ 0.23 s). Hormonal replacement with dexamethasone (50*/day) did not affect reaction time (3.38 ñ 0.19 s). However, this response was restored by combined adrenal and gonadal steroid substitution (estradiol 5*g/day and progesterone 1.5*g 6h before the test) therapy (5.11 ñ 0.45 s) in animal treated with dexamethasone plus estradiol and 5.04 ñ 0.43 s in animals treated with dexamethasone plus estradiol plus progesterone). Naloxone (2mg/Kg decreased the reaction time of animals treated with adrenal and gonadal steroids (5.11 ñ 0.45 vs 4.15 ñ 0.44 and 5.04 ñ 0.43 vs 3.87 ñ 0.28 s, respectively, before and after naloxone) but failed to decrease it in rats treated with dexamethasone only (3.88 ñ 0.18 vs 4.34 ñ 0.25 s, before and after naloxone). These observations indicate that gonadal steroids are the most important steroid factors involved in the reaction time to tail immersion in hot water and confirm other reports that the opioid pathways modulating the neuronal circuitry require the presence of these hormones
Subject(s)
Rats , Animals , Female , Adrenal Glands/drug effects , Estradiol/pharmacology , Ovary/drug effects , Pain Measurement/drug effects , Progesterone/pharmacology , Receptors, Opioid/drug effects , Dexamethasone/pharmacology , Dexamethasone/therapeutic use , Disease Models, Animal , Endorphins/antagonists & inhibitors , Endorphins/pharmacology , Estradiol/therapeutic use , Immersion , Naloxone/pharmacology , Naloxone/therapeutic use , Progesterone/therapeutic use , Rats, Wistar , Tail/drug effects , Time Factors , WaterABSTRACT
The analgesic response was evaluated by the tail immersion test in female rats during each phase of rhe estrous cycle. The reaction time (mean ñ SEM) for tail witdrawal from the hot water bath was faster during proestrus (5.78 ñ 0,28s) and decreased significantly during estrus (5.31 ñ 0.30s) and diestrus 1 (5.40 ñ 0.21s). Blockade of opiate receptors with naloxone (2mg/Kg, ip) invreased the sensitivity to the noxious stimulus only during proestrus (6.46 ñ 0.42 vs 5.02 ñ 0.41 s). These results suggest that the effects of gonadal steroids on nociception may involve an opioid pathway